Picterus Jaundice mHealth platform · Bringing newborn care home: An integral mHealth solution for neonatal jaundice management.

Neonatal jaundice (NNJ) affects 60%-80% of newborns worldwide (84-112 million/year). Ten percent will develop severe jaundice (SNJ), which can cause permanent brain damage or even death (114,000 newborns die/year, 75,000 suffer severe long-term neurological impairments). A fast, point-of-care, affordable method for NNJ screening and monitoring in the first 2 weeks of life is crucial, but current methods are insufficient (e.g. visual assessment, transcutaneous device, blood test).Health systems face increasing pressure on their resources. It is imperative to develop more sustainable models of care and empower patients and their families.Picterus is developing the first digital platform to enable NNJ screening by parents and caregivers at home, and a timely referral to healthcare services. Our recommendation tool will allow families to monitor NNJ at home with their smartphones, and healthcare workers to efficiently manage a greater number of families by avoiding unnecessary visits.